Corporate Ventures Fund of Merck KGaA, Darmstadt, Germany, Creates New Immuno-Oncology Company iOnctura June 20, 2017July 11, 2017 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: Thermo Fisher Scientific Opens Call for Grant…SPT Labtech announces acquisition by EQT Private…Thermo Fisher Scientific Announces Oncomine Clinical…Teen Scientist Creates Novel Diagnostic Tool for…Roche enters partnership with the Global Fund to…Illumina Invests in £30M Venture Fund to Advance…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
